open access

Vol 65, No 4 (2015)
Review paper
Published online: 2015-09-11
Get Citation

Totally implantable venous access devices in cancer patients

Marian Domurat, Ewa Sierko, Marek Z. Wojtukiewicz
DOI: 10.5603/NJO.2015.0060
·
Nowotwory. Journal of Oncology 2015;65(4):302-316.

open access

Vol 65, No 4 (2015)
Review article
Published online: 2015-09-11

Abstract

Totally implantable venous access devices (TIVDs) are very convenient, long-term accesses to the central venous vessel. They constitute an indispensable solution for patients with difficulties in accessing peripheral veins requiring chemotherapy, parenteral nutrition, antibiotics and frequent blood samples for testing. Port devices are implanted by physicians of different specialties: surgeons, anaesthesiologists, oncologists and radiologists. Vessel cannulation also can be different: open with venotomy or percutaneous puncture. In order to gain access to the central vein: most commonly used are the right internal jugular and right subclavian veins. Implantation of vascular ports as with any interventional treatment, involves the possibility of acute, early and late complications. Acute complications are directly related to the surgery and are the result of abnormal implantation techniques or anatomical abnormalities. Among the late complications in oncology two are particularly troublesome: catheter-related bloodstream infection and thrombosis. Despite their all limitations and complications associated with the use of vascular ports: for more than three decades was no alternative. Further technological development and education of medical staff allows the use of implantable vascular access systems in many patients, giving great benefit to the therapy and improvement of the quality of life of cancer patients.

Abstract

Totally implantable venous access devices (TIVDs) are very convenient, long-term accesses to the central venous vessel. They constitute an indispensable solution for patients with difficulties in accessing peripheral veins requiring chemotherapy, parenteral nutrition, antibiotics and frequent blood samples for testing. Port devices are implanted by physicians of different specialties: surgeons, anaesthesiologists, oncologists and radiologists. Vessel cannulation also can be different: open with venotomy or percutaneous puncture. In order to gain access to the central vein: most commonly used are the right internal jugular and right subclavian veins. Implantation of vascular ports as with any interventional treatment, involves the possibility of acute, early and late complications. Acute complications are directly related to the surgery and are the result of abnormal implantation techniques or anatomical abnormalities. Among the late complications in oncology two are particularly troublesome: catheter-related bloodstream infection and thrombosis. Despite their all limitations and complications associated with the use of vascular ports: for more than three decades was no alternative. Further technological development and education of medical staff allows the use of implantable vascular access systems in many patients, giving great benefit to the therapy and improvement of the quality of life of cancer patients.

Get Citation
About this article
Title

Totally implantable venous access devices in cancer patients

Journal

Nowotwory. Journal of Oncology

Issue

Vol 65, No 4 (2015)

Article type

Review paper

Pages

302-316

Published online

2015-09-11

Page views

896

Article views/downloads

14509

DOI

10.5603/NJO.2015.0060

Bibliographic record

Nowotwory. Journal of Oncology 2015;65(4):302-316.

Authors

Marian Domurat
Ewa Sierko
Marek Z. Wojtukiewicz

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl